๐Ÿ‡ฎ๐Ÿ‡ชIreland
16ยฐC Partly Cloudy ยท Dublin
Live Updates
--:--:-- IST
Writer Login
Latest
Priya Life Science Clinical trial register
TrackersDrugsComparisonsAPI
Trackers› Clinical trials› Head & Neck Cancer
Clinical trial register · China

Head & Neck Cancer Trials in China, 2026

Every study on the ClinicalTrials.gov registry that lists a site in China and is open, about to open, active-but-closed, or enrolling by invitation. Filter it, cite it, and take it away as a file.

Download CSV
Source: ClinicalTrials.gov, U.S. National Library of Medicine. Complete coverage โ€” all 19052 matching records held by the registry are in this view. Synced 22 Sep 2026, 11:10 UTC
19052
Studies in scope
all four open statuses
11786
Recruiting now
open to new participants
2009
Lead sponsors
across recruiting studies
Top sites
Shanghai 2 Beijing 1 Wuxi 1 Xiโ€™an 1 Shanxi 1
Narrow the registerReset
Recruitment status
Phase
Site location
Shanghai2 Beijing1 Wuxi1 Xiโ€™an1 Shanxi1
All 9 locations
Target enrolment
to

Head & Neck Cancer trials in China

10 of 19052 studies
Download
Status
Study
Lead sponsor
Phase
Enrol
Chinese sites
Start
Not yet open
Nimotuzumab Plus Radiotherapy in Elderly Patients With Locally Advanced Head and Neck Squamous Cell Carcinoma
NCT07821242Head & Neck Cancer, Radiotherapy
Ke Hu
Phase 2
46
Beijing
2026-09-10
Not yet open
Penpulimab Combined With Chemotherapy for Patients With Locally Advanced Hypopharyngeal Carcinoma
NCT07752394Head & Neck Cancer
Tang-Du Hospital
Phase 2
15
Xiโ€™an
2026-08-23
Recruiting
The Safety, Dosimetry and Efficacy of 177Lu-INN805 in Patients With Malignant Solid Tumors
NCT07459283Maligant Solid Tumor, Head & Neck Cancer, Thyroid Cancer, Lung Cancer - Non Small Cell Squamous
FindCure Biosciences (ZhongShan) Co., Ltd.
Phase EARLY_PHASE1
10
Wuxi
2026-04-20
Recruiting
Nimotuzumab Combined With Immunotherapy and Chemotherapy in the Treatment of Locally Advanced Head and Neck Squamous Cell Carcinoma
NCT07601737Head and Neck Squamous Cell Carcinoma, Head and Neck Squamous Cell Carcinoma (HNSCC), Head & Neck Cancer, Neoadjuvant Therapy
Shanghai General Hospital, Shanghai Jiao Tong University School of Medicine
Phase 2
182
Shanghai
2026-04-20
Recruiting
Intratumoral Injection of Recombinant Human Endostatin Adenovirus (EDS01) for the Treatment of Recurrent or Metastatic Head and Neck Tumors
NCT07625423Head & Neck Cancer, Nasopharyngeal Cancinoma (NPC)
West China Hospital
Phase 1
9
Chengdu
2026-03-27
Recruiting
Postoperative Radiotherapy Combined With Nimotuzumab Followed by Benmelstobart in High-Risk Patients With Head and Neck Squamous Cell Carcinoma
NCT07445048Head & Neck Squamous Cell Carcinoma, Head & Neck Cancer, Postoperative Adjuvant Treatment
Shanghai Ninth People's Hospital Affiliated to Shanghai Jiao Tong University
Phase 3
370
Shanghai
2026-03-04
Recruiting
Compare Radiotherapy Plus Nimotuzumab Versus Radiotherapy Alone in Platinum-ineligible Patients With Locoregionally Advanced Head and Neck Squamous Cell Carcinoma
NCT07333274Head & Neck Squamous Cell Carcinoma, Head & Neck Cancer
Shandong Cancer Hospital and Institute
Phase 3
335
Shandong
2026-01-05
Recruiting
FL-261 Imaging for Cancer Diagnosis and Staging
NCT07510321Non-Small Cell Lung Cancer, Colorectal Cancer, Head & Neck Cancer, Advanced Solid Tumors
Union Hospital, Tongji Medical College, Huazhong University of Science and Technology
Observational
12
Wuhan
2025-11-27
Recruiting
Specialist Nurse-Led Nursing Management for Patients Undergoing Head and Neck Cancer Surgery
NCT07622381Head & Neck Cancer
Tianjin Medical University Cancer Institute and Hospital
Not applicable
80
Tianjin
2025-11-24
Recruiting
Nimotuzumab Combined With Toripalimab and Chemotherapy for Locally Advanced Tonsillar Cancer
NCT07353723Head & Neck Cancer
Tang-Du Hospital
Phase 2
10
Shanxi
2025-11-15
Rows per page Showing 1–10 of 10
1
Cite this view

Priya Life Science (2026). Clinical trial register: studies with a Chinese investigative site, filtered. Derived from ClinicalTrials.gov. Retrieved 25 September 2026. https://priyalifescience.com/clinical-trials-china/condition/head-neck-cancer

Query this register directly
GET /api/trials?country=cn&status=recruiting&format=json Try it now →

About this register

This register is built from ClinicalTrials.gov, the trial registry run by the U.S. National Library of Medicine. It includes every study on the registry that lists at least one investigative site in China and is recruiting, not yet recruiting, active but no longer recruiting, or enrolling by invitation: 19,052 studies in total at the last sync on 22 Sep 2026, 11:10 UTC. The full list can be downloaded as CSV or queried as JSON through the register API.

This page shows the 10 of those studies listing the condition Head & Neck Cancer.

How many Head & Neck Cancer trials are recruiting in China?

8 of the 10 studies on this page are recruiting new participants as of the 22 Sep 2026, 11:10 UTC sync. A further 2 have not yet opened recruitment, 0 are active but closed to new participants, and 0 are enrolling by invitation only. Eligibility for any study is decided by its study team.

Summary by phase

Studies by phase (Head & Neck Cancer), 10 studies
PhaseStudiesRecruitingShare
Phase 24240%
Phase 32220%
Not applicable1110%
Observational1110%
Phase 11110%
Phase EARLY_PHASE11110%

Most active sponsors

Lead sponsors with the most studies (Head & Neck Cancer)
Lead sponsorStudiesRecruiting
Tang-Du Hospital21
FindCure Biosciences (ZhongShan) Co., Ltd.11
Ke Hu10
Shandong Cancer Hospital and Institute11
Shanghai General Hospital, Shanghai Jiao Tong University School of Medicine11
Shanghai Ninth People's Hospital Affiliated to Shanghai Jiao Tong University11
Tianjin Medical University Cancer Institute and Hospital11
Union Hospital, Tongji Medical College, Huazhong University of Science and Technology11
West China Hospital11
Listing here is informational and not medical advice; eligibility is determined by each study team. See also the Ireland, UK, EU, USA and India registers.